210 related articles for article (PubMed ID: 34780841)
1. Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris Color.
Wierenga APA; Brouwer NJ; Gelmi MC; Verdijk RM; Stern MH; Bas Z; Malkani K; van Duinen SG; Ganguly A; Kroes WGM; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Ophthalmology; 2022 Apr; 129(4):421-430. PubMed ID: 34780841
[TBL] [Abstract][Full Text] [Related]
2. Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1.
Gelmi MC; Wierenga APA; Kroes WGM; van Duinen SG; Karuntu JS; Marinkovic M; Bleeker JC; Luyten GPM; Vu THK; Verdijk RM; Jager MJ
Ophthalmol Sci; 2023 Sep; 3(3):100297. PubMed ID: 37193315
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.
Dogrusöz M; Bagger M; van Duinen SG; Kroes WG; Ruivenkamp CA; Böhringer S; Andersen KK; Luyten GP; Kiilgaard JF; Jager MJ
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):833-842. PubMed ID: 28159971
[TBL] [Abstract][Full Text] [Related]
5. Genetic Status Affects Disease-Specific Mortality But Not the Incidence of Local Recurrence in Patients with Uveal Melanoma.
Bagger M; Espensen C; Rasmussen K; Dogrusöz M; Jager MJ; Appelt A; Kiilgaard JF
Ophthalmology; 2023 Aug; 130(8):822-829. PubMed ID: 36934828
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma.
van Beek JG; Koopmans AE; Vaarwater J; de Rooi JJ; Paridaens D; Naus NC; de Klein A; Verdijk RM; Kiliç E
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1284-91. PubMed ID: 24508790
[TBL] [Abstract][Full Text] [Related]
7. Impact of iris color on uveal melanoma-related outcomes in 7245 patients at a single ocular oncology center.
Zaloga AR; DeYoung C; Kurian DE; Card KR; Caudill GB; Zeiger JS; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(1):100031. PubMed ID: 38383076
[TBL] [Abstract][Full Text] [Related]
8. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
[TBL] [Abstract][Full Text] [Related]
9. Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal Melanoma.
Gelmi MC; Bas Z; Malkani K; Ganguly A; Shields CL; Jager MJ
Ophthalmology; 2022 Apr; 129(4):431-437. PubMed ID: 34793831
[TBL] [Abstract][Full Text] [Related]
10. Iris Colour and the Risk of Developing Uveal Melanoma.
Houtzagers LE; Wierenga APA; Ruys AAM; Luyten GPM; Jager MJ
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998469
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
12. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA
Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428
[TBL] [Abstract][Full Text] [Related]
13. 8q Gain Has No Additional Predictive Value in
Nguyen JQN; Drabarek W; Vaarwater J; Yavuzyigitoglu S; Verdijk RM; Paridaens D; Naus NC; de Klein A; Brosens E; Kiliç E;
Ophthalmol Sci; 2024; 4(2):100413. PubMed ID: 38187129
[TBL] [Abstract][Full Text] [Related]
14. Correlation of fitzpatrick skin type and iris color with tumor size in 823 patients with uveal melanoma.
Agrawal KU; Barke MR; Chiang L; Ni R; Kim RS; Zhang Q; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100046. PubMed ID: 38320655
[TBL] [Abstract][Full Text] [Related]
15. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
16. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
[TBL] [Abstract][Full Text] [Related]
17. Lack of tumour pigmentation in conjunctival melanoma is associated with light iris colour and worse prognosis.
Brouwer NJ; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Br J Ophthalmol; 2019 Mar; 103(3):332-337. PubMed ID: 29777046
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
20. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
Shields CL; Say EAT; Hasanreisoglu M; Saktanasate J; Lawson BM; Landy JE; Badami AU; Sivalingam MD; Hauschild AJ; House RJ; Daitch ZE; Mashayekhi A; Shields JA; Ganguly A
Ophthalmology; 2017 Oct; 124(10):1523-1531. PubMed ID: 28495150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
